West Chester, PA, United States of America

Dimitrios Sarantakis

This inventor holds 72 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Leukocyte Adhesion Inhibition (CPC class 2601). Top assignees: American Home Products Corporation, Elan Pharmaceuticals, Inc., Wyeth. Active years: 1976-2011.

USPTO Granted Patents = 72

% Patents Active = 80.6

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 1

Average Co-Inventor Count = 1.5

ph-index = 12

Forward Citations = 562(Granted Patents)

Forward Citations (Not Self Cited) = 525(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Chester, PA (US) (1976)
West Chester, PA (US) (1976 - 1985)
Newtown, PA (US) (1993 - 2011)
Newton, PA (US) (2010 - 2011)

Company Filing History:

47 out of 1,567

American Home Products Corporation

patents

12 out of 202

Elan Pharmaceuticals, Inc.

4. 12 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2011

Loading Chart...

Areas of Expertise:

Leukocyte Adhesion

Heteroaryl Compounds

Integrin Inhibitors

Alpha Amino Acids

Beta Amino Acids

Carbamyloxy Compounds

Phenylalanine Derivatives

Cyclic Hexapeptides

Somatostatin Analogues

Dipeptides

Peptide Compositions

Antihypertensive Activity

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-07-05),

2. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-06-28),

3. 7745454 - Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2010-06-29),

4. 7378529 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-05-27),

5. 7320960 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-01-22),

6. 7291645 - Phenylalanine derivatives as alpha 4 integrin inhibitors (2007-11-06),

7. 7229970 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-06-12),

8. 7223762 - Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2007-05-29),

9. 7166580 - Compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-01-23),

10. 7015216 - Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors (2006-03-21),

11. 6953802 - Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2005-10-11),

12. 6949570 - Compounds which inhibit leukocyte adhesion mediated by VLA-4 (2005-09-27),

13. 6900179 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2005-05-31),

14. 6803370 - Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4 (2004-10-12),

15. 6794506 - 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2004-09-21),

Title: The Innovative Mind of Dimitrios Sarantakis

Introduction: Dimitrios Sarantakis, a brilliant inventor based in West Chester, PA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Dimitrios Sarantakis holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Dimitrios Sarantakis has worked tirelessly to bring his innovative ideas to life. He has been recognized for his exceptional problem-solving skills and creative approach to invention.

Collaborations: Throughout his career, Dimitrios Sarantakis has collaborated with leading research institutions, universities, and tech companies to further develop and implement his inventions. His collaborative spirit has led to the successful realization of numerous cutting-edge technologies.

Conclusion: Dimitrios Sarantakis continues to push the boundaries of innovation, inspiring the next generation of inventors with his remarkable achievements and groundbreaking inventions.